Comparing efficacy and safety of glucagon-like peptide 1 agonist versus sodium-glucose cotransporter 2 (SGLT-2) inhibitors in Chinese patients with type 2 diabetes mellitus
Page No: 00
By: Yuanbo Wei, Huihui Ma, Tianshuai Wei
Keywords: Dulaglutide; SGLT-2 inhibitor; Glucagon-like peptide-1; Dapagliflozin; Diabetes mellitus
DOI : 10.36721/PJPS.0000.00.0.REG.000-000.1
[View Complete Article]
By: Yuanbo Wei, Huihui Ma, Tianshuai Wei
Keywords: Dulaglutide; SGLT-2 inhibitor; Glucagon-like peptide-1; Dapagliflozin; Diabetes mellitus
DOI : 10.36721/PJPS.0000.00.0.REG.000-000.1
Abstract: To compare efficacy and safety of Dula vs. dapagliflozin in Chinese T2DM patients
[View Complete Article]